United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Capricor Therapeutics announces promising long-term results for deramiocel deramiocel in Duchenne muscular dystrophy Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company at the forefront of developing cell and exosome-based therapies, has shared… byPallavi MadhirajuJune 29, 2024